188 related articles for article (PubMed ID: 8388505)
1. Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons.
Khan MA; Tolleson WH; Gangemi JD; Pirisi L
J Virol; 1993 Jun; 67(6):3396-403. PubMed ID: 8388505
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid suppresses human papillomavirus type 16 (HPV16)-mediated transformation of human keratinocytes and inhibits the expression of the HPV16 oncogenes.
Creek KE; Jenkins GR; Khan MA; Batova A; Hodam JR; Tolleson WH; Pirisi L
Adv Exp Med Biol; 1994; 354():19-35. PubMed ID: 8067286
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes.
Khan MA; Jenkins GR; Tolleson WH; Creek KE; Pirisi L
Cancer Res; 1993 Feb; 53(4):905-9. PubMed ID: 8381332
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNA.
Khan MA; Canhoto AJ; Housley PR; Creek KE; Pirisi L
Exp Cell Res; 1997 Oct; 236(1):304-10. PubMed ID: 9344611
[TBL] [Abstract][Full Text] [Related]
6. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids.
Pirisi L; Batova A; Jenkins GR; Hodam JR; Creek KE
Cancer Res; 1992 Jan; 52(1):187-93. PubMed ID: 1370074
[TBL] [Abstract][Full Text] [Related]
7. HPV16-transformed human keratinocytes depend on SIX1 expression for proliferation and HPV E6/E7 gene expression.
Hosseinipour M; Wan F; Altomare D; Creek KE; Pirisi L
Virology; 2019 Nov; 537():20-30. PubMed ID: 31425971
[TBL] [Abstract][Full Text] [Related]
8. Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes.
Creek KE; Geslani G; Batova A; Pirisi L
Adv Exp Med Biol; 1995; 375():117-35. PubMed ID: 7645423
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.
Borger DR; Mi Y; Geslani G; Zyzak LL; Batova A; Engin TS; Pirisi L; Creek KE
Virology; 2000 May; 270(2):397-407. PubMed ID: 10792999
[TBL] [Abstract][Full Text] [Related]
10. Different HPV16 E6/E7 oncogene expression patterns in epithelia reconstructed from HPV16-immortalized human endocervical cells and genital keratinocytes.
Sun Q; Tang SC; Pater MM; Pater A
Oncogene; 1997 Nov; 15(20):2399-408. PubMed ID: 9395236
[TBL] [Abstract][Full Text] [Related]
11. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.
Sedman SA; Barbosa MS; Vass WC; Hubbert NL; Haas JA; Lowy DR; Schiller JT
J Virol; 1991 Sep; 65(9):4860-6. PubMed ID: 1651408
[TBL] [Abstract][Full Text] [Related]
12. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
Baldwin A; Pirisi L; Creek KE
J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid induces secretion of latent transforming growth factor beta 1 and beta 2 in normal and human papillomavirus type 16-immortalized human keratinocytes.
Batova A; Danielpour D; Pirisi L; Creek KE
Cell Growth Differ; 1992 Nov; 3(11):763-72. PubMed ID: 1334692
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.
Hypes MK; Pirisi L; Creek KE
Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999
[TBL] [Abstract][Full Text] [Related]
15. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes.
Agarwal C; Hembree JR; Rorke EA; Eckert RL
Cancer Res; 1994 Apr; 54(8):2108-12. PubMed ID: 8174114
[TBL] [Abstract][Full Text] [Related]
16. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells.
Halbert CL; Demers GW; Galloway DA
J Virol; 1992 Apr; 66(4):2125-34. PubMed ID: 1312623
[TBL] [Abstract][Full Text] [Related]
17. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression.
Mi Y; Borger DR; Fernandes PR; Pirisi L; Creek KE
Virology; 2000 May; 270(2):408-16. PubMed ID: 10793000
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the EGF receptor promoter by HPV16 and retinoic acid in human ectocervical epithelial cells.
Sizemore N; Choo CK; Eckert RL; Rorke EA
Exp Cell Res; 1998 Oct; 244(1):349-56. PubMed ID: 9770378
[TBL] [Abstract][Full Text] [Related]
19. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
20. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.
Hawley-Nelson P; Vousden KH; Hubbert NL; Lowy DR; Schiller JT
EMBO J; 1989 Dec; 8(12):3905-10. PubMed ID: 2555178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
